Tacrine (THA) was evaluated in vitro and in vivo as a pretreatment for
nerve agent intoxication. In vitro experiments showed that the primar
y effect of THA was direct inhibition of purified fetal bovine serum a
cetylcholinesterase (AChE) with a slight effect on slowing the aging r
ate of nerve agent-inhibited AChE. THA produced significant behavioral
effects at doses above 1.7 mg/kg, i.m., in the mouse and 3.4 mg/kg, i
.m., in the guinea pig. At the no observable effect level (NOEL) for m
ice (1.7 mg/kg), THA was effective (P less than or equal to 0.05) in r
educing tabun- and soman-, but not sarin-induced lethality in mice. Ex
periments in the guinea pig showed that at the NOEL (3.4 mg/kg, i.m.)
THA was not effective in decreasing lethality due to soman exposure. S
ince there was significant overlap between pharmacologically effective
doses of THA and those which produce behavioral toxicity, THA was not
considered a suitable pretreatment for nerve agent intoxication.